While grilling Novo Nordisk’s chief executive over the price of its blockbuster diabetes and weight-loss drugs, Ozempic and ...
A committee report found the weight loss drug is offered for less than $100 in some European countries, compared to monthly ...
Semaglutide, the underlying drug marketed as Ozempic and Wegovy, works by mimicking a hormone that triggers the body to feel ...
Novo Nordisk CEO grilled over company's pricing for the diabetes drug Ozempic and the weight-loss drug Wegovy.
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. People who take Ozempic for diabetes may be at lower risk of drug overdose, ...
Her doctor told her that Ozempic, a medication approved by the U.S. Food and Drug Administration to treat Type 2 diabetes ...
On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback